Reardon Andrew — SEC insider filings

SEC reporting owner CIK 1950232. 29 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2022-12-01 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIGAND PHARMACEUTICALS INC (LGND)CLO & Secretary29—80 legs · 60,800 sh · $13,286,59952

Insider filings — Reardon Andrew

FiledFormIssuerReported transactionsSource
2026-11-044LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 5,000 @ $52.27 · Sale (S): 283 @ $307.39 · Sale (S): 708 @ $308.43 · Sale (S): 522 @ $309.91 · Sale (S): 490 @ $310.61 · Sale (S): 520 @ $311.72 · +9 moreEDGAR
2026-10-064LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 340 @ $52.27 · Sale (S): 833 @ $302.51 · Sale (S): 1,976 @ $303.54 · Sale (S): 1,535 @ $304.52 · Sale (S): 404 @ $306.18 · Sale (S): 235 @ $307.19 · +2 moreEDGAR
2026-09-084LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 300 @ $283.99 · Sale (S): 1,800 @ $285.17 · Sale (S): 2,115 @ $286.36 · Sale (S): 385 @ $287.53 · Sale (S): 400 @ $288.98EDGAR
2026-08-044LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 5,000 @ $52.27 · Sale (S): 105 @ $284.14 · Sale (S): 33 @ $284.55 · Sale (S): 157 @ $285.74 · Sale (S): 1,032 @ $286.80 · Sale (S): 1,214 @ $287.77 · +6 moreEDGAR
2026-07-064LIGAND PHARMACEUTICALS INC (LGND)Other (J): 132 @ $160.71 · Option exercise (M): 5,000 @ $52.27 · Sale (S): 396 @ $308.99 · Sale (S): 104 @ $310.20 · Sale (S): 1,119 @ $311.72 · Sale (S): 1,081 @ $312.28 · +5 moreEDGAR
2026-06-024LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 5,000 @ $52.27 · Sale (S): 491 @ $223.95 · Sale (S): 677 @ $225.20 · Sale (S): 1,432 @ $225.97 · Sale (S): 400 @ $226.78 · Sale (S): 584 @ $228.57 · +3 moreEDGAR
2026-05-044LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 5,000 @ $52.27 · Sale (S): 600 @ $227.45 · Sale (S): 932 @ $228.75 · Sale (S): 98 @ $229.71 · Sale (S): 370 @ $230.87 · Sale (S): 780 @ $232.04 · +3 moreEDGAR
2026-04-024LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 5,000 @ $52.27 · Sale (S): 460 @ $198.85 · Sale (S): 1,302 @ $199.72 · Sale (S): 1,238 @ $200.94 · Sale (S): 700 @ $201.90 · Sale (S): 963 @ $203.22 · +2 moreEDGAR
2026-03-274LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 4,513 @ $0 · Grant/award (A): 21,525 (derivative) @ $0EDGAR
2026-03-064LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 5,000 @ $52.27 · Sale (S): 100 @ $197.70 · Sale (S): 100 @ $199.00 · Sale (S): 207 @ $199.96 · Sale (S): 93 @ $200.62 · Sale (S): 300 @ $201.70 · +7 moreEDGAR
2026-02-184LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 6,928 @ $0 · Tax withholding (F): 3,211 @ $183.83 · Grant/award (A): 8,810 @ $0 · Tax withholding (F): 4,083 @ $183.83 · Tax withholding (F): 593 @ $183.83 · Tax withholding (F): 801 @ $183.83 · +1 moreEDGAR
2025-08-124LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 1,325 @ $150.06EDGAR
2025-07-024LIGAND PHARMACEUTICALS INC (LGND)Other (J): 233 @ $91.08EDGAR
2025-06-244LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 500 @ $114.08EDGAR
2025-06-124LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 500 @ $114.54EDGAR
2025-06-024LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 897 @ $100.16 · Sale (S): 1,000 @ $104EDGAR
2025-03-064LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 6,415 @ $0 · Grant/award (A): 28,043 (derivative) @ $0EDGAR
2025-02-194LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 6,928 @ $0 · Tax withholding (F): 2,775 @ $120 · Grant/award (A): 5,429 @ $0 · Tax withholding (F): 1,758 @ $120 · Tax withholding (F): 1,114 @ $120 · Tax withholding (F): 876 @ $120EDGAR
2024-09-254LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,000 @ $52.27 · Sale (S): 2,000 @ $99.60 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2024-08-304LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 1,500 @ $52.27 · Sale (S): 1,500 @ $106.39 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2024-07-024LIGAND PHARMACEUTICALS INC (LGND)Other (J): 329 @ $60.71EDGAR
2024-05-134LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 10,000 @ $52.27 · Sale (S): 10,000 @ $83.04 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-02-294LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 7,208 @ $0 · Grant/award (A): 29,272 (derivative) @ $0EDGAR
2024-02-164LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 593 @ $74.65EDGAR
2024-01-044LIGAND PHARMACEUTICALS INC (LGND)Other (J): 179 @ $60.71EDGAR
2023-08-144LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 897 @ $68.73EDGAR
2023-03-284LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 300 @ $69.92EDGAR
2023-02-274LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 5,668 @ $0 · Grant/award (A): 15,393 (derivative) @ $0EDGAR
2022-12-014LIGAND PHARMACEUTICALS INC (LGND)Tax withholding (F): 1,073 @ $72.90EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1950232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs